The Royal Brompton and Harefield Hospitals
London, SW6 3NP, United Kingdom
NCT Number: NCT05796817
In normal practice oxygen supply can be easily met with existing hospital infrastructure. COVID - 19 however results in lung damage which greatly increases the amount of oxygen patients require - as a consequence some hospitals in the UK and other countries had situations where there was not enough oxygen for their inpatients.
COVID - 19 has caused many more patients to requiring assistance with their breathing using a ventilator. Due to the limited supply of sophisticated ventilators that 're-use' oxygen patients breathe out, some hospitals have used ventilators normally used by patients at home (domiciliary ventilators). Whilst these are inexpensive and commonly available, any oxygen the patient breathes out is simply released into the atmosphere.
The address this problem, and in turn reduce the oxygen demand on hospital infrastructure the biomedical engineering team (BME) at the Royal Brompton Hospital, London devised a simple 3-D printed modification which captures and reuses oxygen on commonly used domiciliary ventilators. Laboratory testing found this modification can increase the oxygen given by the ventilator without increasing the oxygen consumption of the ventilator - effectively reducing oxygen demand on hospital infrastructure.
This study will evaluate this modification in patients admitted to intensive care requiring assistance with their breathing. This will involve measuring oxygen levels on domiciliary ventilators (Breas Nippy 4+, ResMed Lumis 150 or Vivo 1, 2 or 3) with and without the modification and with small increases in oxygen supplied to the patient for a total study period of 2 hours.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
London, SW6 3NP, United Kingdom
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The ventilator modification will be fitted to a ResMed Lumis 150, Breas® Nippy 4+ or Vivo 1, 2 or 3 ventilator. The participants oxygen level will be measured with and without the modification in place at their baseline ventilation, and with 1, 2 and 3 litres oxygen extra to their baseline. the researcher will then leave the modification on and slowly reduce the oxygen going into the ventilator, maintaining the participants SP02 at an acceptable level (>95%)
Time frame: After 10 minutes
PaO2 with and without modification fitted
Time frame: After 10 minutes of each experimental condition
Oxygenation with and without modification in place with 1, 2 and 3 litres added to baseline FiO2
Time frame: After 10 minutes of each experimental condition
Arterial CO2 levels at each experimental condition
Royal Brompton & Harefield NHS Foundation Trust
Other
Reducing Oxygen Consumption in Critical Care (ROCC)
Acronym: ROCC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04021615
Mechanical Ventilation Complication
Cairo, Cairo Governorate, Egypt
View Trial DetailsNCT03129217
Diaphragm Injury, Mechanical Ventilation Complication
Toronto, Ontario, Canada
View Trial DetailsNCT03108118
Diaphragm Injury, Mechanical Ventilation Complication
Toronto, Ontario, Canada
View Trial DetailsNCT05991258
Acute Respiratory Failure, Lung Diseases
Padua, Italy
View Trial Details